Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry

11 Feb 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Pancreatic function and diabetes
Share to Phagocytosis and Immune Regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35150639
DOI: 10.1016/j.cmet.2022.01.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entryPMID 35150639Read ↗

Advances in Targeting ACE2 for Developing COVID-19 TherapeuticsSemantic proximity Read ↗

ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosisSemantic proximity Read ↗

USP18 Curbs the Progression of Metabolic Hypertension by Suppressing JAK/STAT PathwaySemantic proximity Read ↗

Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2–induced systemic toxicitySemantic proximity Read ↗

Development of an in Vitro Model to Investigate the Regulation of ACE2 Expression and its Correlation with ACE2-Mediated Viral EntrySemantic proximity Read ↗

[Ⅳ. IDH Inhibitor].Semantic proximity Read ↗

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expressionSemantic proximity Read ↗

Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseasesSemantic proximity Read ↗

Protein kinase CK2: a potential therapeutic target for diverse human diseases.Semantic proximity Read ↗

Systematic Cell Line-Based Identification of Drugs Modifying <i>ACE2</i> ExpressionSemantic proximity Read ↗

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cellsSemantic proximity Read ↗

Histone Deacetylase Inhibitors and Diabetic Kidney DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.